MOU Signing for Localization of Biologic Manufacturing

MOU Signing for Localization of Biologic Manufacturing

On the 16th of December 2020, SaudiVax Ltd. under the patronage of His Excellency Eng. Khalid Alfalih, Minister of Investment, celebrated the signing of a memorandum of understanding (MOU) with Johnson & Johnson Middle East FZ LLC to localize the manufacturing of leading biological drugs. This will establish SaudiVax as the manufacturing partner of Johnson & Johnson in the Kingdom of Saudi Arabia, locally producing drug products in the highest quality.

Johnson & Johnson is a leading pharmaceutical company in the field of biologics for helping patients with autoimmune inflammatory conditions such as plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Janssen products provide great value to patients around the world through their proven efficacy, safety and quality profiles.

SaudiVax Ltd. is striving to be an addition of value to the Saudi biopharmaceutical industry, and the Saudi economy holistically. It is a major stride towards national self-sufficiency through local manufacturing and industrialization of biologics and vaccines in the Kingdom, in accordance with the SaudiVision 2030. Such partnerships are vital, especially with the recent circumstances of the COVID-19 pandemic and its effects on international borders, local manufacturing of drug products can highly benefit both parties by ensuring the continuation of supply chain and the availability of important medicines.

About SaudiVax Ltd:

SaudiVax is a leading biotechnology company in the Kingdom and a joint venture of “UYC Inc.” of Saudi Arabia and “PnuVax Inc.” of the USA. The mission of SaudiVax is to localize biotechnology in Saudi Arabia, the Gulf Cooperation Council (GCC), & the Organisation of Islamic Countries (OIC). SaudiVax is particularly keen to ensure national health security by supporting the region’s pandemic preparedness plans against infectious diseases. In alignment with the SaudiVision 2030, SaudiVax is promoting women employment in the biotechnology sector, and supporting the creation of high-income jobs for highly educated and talented Saudi graduates. SaudiVax is striving to be the 1st local manufacturer for “high demand” biotechnology products, creating a label in Saudi Arabia, and for exporting to the OIC members, to build needed ecosystems covering research, development, manufacturing and training to secure technology and knowledge transfer.

Contact Information:

Dr. Noor Zaouri and Ms. Hanin Nasir

4700 King Abdullah University of Science and Technology (KAUST)

Innovation Cluster 3

Thuwal 23955-6900, Kingdom of Saudi Arabia

e-mail: admin@saudivax.com